Iceni Diagnostics addresses opportunities and unmet needs in point of care diagnostics and carbohydrate-based therapeutics, with a focus in infectious disease. The company provides bespoke solutions in glycoscience R&D, nanoparticle technology and bioconjugation chemistry.
Iceni Diagnostics are developing a portfolio of in-house programs, as well as engaging in collaborative and contract R&D activities through engagement with the UK Biotech Sector, Government Research Organisations and academia. Current projects include the development of novel point-of-care diagnostics and new chemical and enzymatic approaches to the production of carbohydrate-containing biopharmaceuticals. Based on the Norwich Research Park, Iceni Diagnostics has immediate access to a wealth of expertise and state-of-the-art platform technologies and that are maintained by the cluster of complementary academic and research institutions on the Park.
Norwich Research Park
Telephone: +44 (0)1603 673665